Novartis to review $600m global media business

Novartis, the pharmaceutical giant, is gearing up to launch a review of its estimated $600m global media business.

Novartis: calls global media review
Novartis: calls global media review

WPP's MEC is the incumbent on the global business, including in the UK.

In 2008 Novartis consolidated its US media planning and buying into MEC after moving its business from sibling agency Mindshare in a global realignment.

The company, which has a consumer health business that markets over the counter medicines such as Tixylix and Savlon, spent £9m in the UK in the past 12 months, according to Nielsen.

Novartis, which is headquartered in Basel, Switzerland, has three other businesses called Pharmaceuticals, Vaccines and Diagnostics, and Sandoz Generics, a global supplier of generic medicines that are produced after a popular medicine's patent has expired.

Have your say...

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus
Media Week Jobs
Search for more media jobs

Latest

Banner ads at 20: why don't people want their faces on elves?

Banner ads at 20: why don't people want their faces on elves?

Graeme Noble, the executive creative director at TMW, reflects on 20 years of digital.

Share
WPP posts 3 per cent rise in third-quarter revenue

WPP posts 3 per cent rise in third-quarter revenue

WPP's third-quarter revenues rose 3.1 per cent to £2.8 billion, according to the company's trading report.

Share
Channel 4 expands interactive ads to mobile

Channel 4 expands interactive ads to mobile

Channel 4 has expanded its interactive ad formats to tablet and mobile devices.

Share

Get news by email